VLC
Van Leeuwen & Company’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $6.7M | Sell |
16,020
-317
| -2% | -$133K | 3.39% | 5 |
|
|
2023
Q4 | $6.65M | Sell |
16,337
-34
| -0.2% | -$13.8K | 3.87% | 4 |
|
|
2023
Q3 | $5.69M | Buy |
16,371
+6,464
| +65% | +$2.25M | 3.55% | 7 |
|
|
2023
Q2 | $3.44M | Buy |
9,907
+216
| +2% | +$75.1K | 2.16% | 16 |
|
|
2023
Q1 | $3.05M | Buy |
9,691
+6,444
| +198% | +$2.03M | 2.05% | 16 |
|
|
2022
Q4 | $938K | Buy |
+3,247
| New | +$938K | 0.65% | 39 |
|
|
2020
Q3 | – | Sell |
-7,719
| Closed | -$2.24M | – | 74 |
|
|
2020
Q2 | $2.24M | Buy |
+7,719
| New | +$2.24M | 1.74% | 25 |
|